This is a Validated Antibody Database (VAD) review about human NR1H4, based on 5 published articles (read how Labome selects the articles), using NR1H4 antibody in all methods. It is aimed to help Labome visitors find the most suited NR1H4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
NR1H4 synonym: BAR; FXR; HRR-1; HRR1; PFIC5; RIP14
Knockout validation
Invitrogen mouse monoclonal (A9033A) |
| Invitrogen NR1H4 antibody (Invitrogen, A9033A) was used in western blot knockout validation on mouse samples (fig s1). JHEP Rep (2021) ncbi |
R&D Systems
mouse monoclonal (A9033A) |
| R&D Systems NR1H4 antibody (R&D, PP-A9033A-00) was used in immunohistochemistry - paraffin section on human samples (fig s4b). J Biol Chem (2022) ncbi |
mouse monoclonal (A9033A) |
| R&D Systems NR1H4 antibody (R&D Systems, PP-A9033A-00) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 1e). Virchows Arch (2021) ncbi |
Invitrogen
mouse monoclonal (A9033A) |
| Invitrogen NR1H4 antibody (Invitrogen, A9033A) was used in western blot knockout validation on mouse samples (fig s1). JHEP Rep (2021) ncbi |
mouse monoclonal (A9033A) |
| In order to study the effect of bile acids on mesenchymal stem cells in liver, Invitrogen NR1H4 antibody (Invitrogen, 417200) was used in immunocytochemistry on rat samples and in western blot on rat samples . Sci Rep (2015) ncbi |
Santa Cruz Biotechnology
mouse monoclonal (D-3) |
| Santa Cruz Biotechnology NR1H4 antibody (Santa Cruz, sc-25309) was used in immunohistochemistry - paraffin section on human samples (fig 2a), in immunocytochemistry on human samples at 1:100 (fig 4b) and in western blot on human samples (fig 1c). Cell Death Dis (2022) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments